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EDITORIAL COMMENTARYTo give or not to give? Are we ready to use noninvasive monitors to
guide fluid management in cardiothoracic surgical patients?Rakesh C. Arora, MD, PhD, FRCSCSee related article on pages 3139-45.Ensuring adequate cardiac output to meet the metabolic
demands of the body’s tissues is the central tenet of manage-
ment for the postoperative cardiac surgical patient.1-3 The
most common therapy in the early postoperative period to
promote this is the use of intravenous fluids. Fluids are
typically infused with the goal of optimizing the Frank-
Starling relationship of ventricular end-diastolic volume
(preload) and stroke volume to optimize cardiac output
and thus forward flow and oxygen delivery.4 A patient’s con-
dition may be deemed fluid ‘‘responsive’’ if the heart
responds to an increase filling volume by increasing its
stroke volume and subsequent cardiac output.5 The impor-
tance of using this therapy appropriately is exemplified by
recent publications in which excessive fluid administration
was associated with increased edema, acute kidney injury,
and mortality.4,6-10 Conversely, harm can also occur with
inappropriate use of inotropes or vasopressors in the
inadequately volume-resuscitated patient.5 It is therefore
important for the bedside clinician to have a reliable means
of accurately determining an individual patient’s optimal
intravascular volume.
The determination of a patient’s need for fluid admin-
istration has traditionally relied on ‘‘static’’ estimation of
intravascular blood volume by the assessment of the right
atrial or central venous pressure through invasive cathe-
ters such as right atrial or pulmonary arterial catheters.
The potential limitations and pitfalls of these monitoring
tools in the cardiothoracic intensive care unit are increas-
ingly apparent.11,12 As described by Kang and colleagues
in their article in this issue of the Journal, the challenge
of appropriate fluid administration for the postoperative
cardiac surgical patient is complex because of the under-
lying cardiac pathology and coexisting comorbidities and
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3146 The Journal of Thoracic and Cardiovascular SurDynamic indicators of alterations in preload, such as res-
piratory changes in right atrial pressure, arterial pressure, and
aortic blood velocity, may be useful for predicting a patient’s
responsiveness to fluid administration.4 As such, there has
been substantial interest in understanding the utility of moni-
toring tools that permit the ‘‘dynamic’’ estimation of recruit-
able cardiac output, such as pulse pressure variation, stroke
volume variation, end-expiratory occlusion test, and inferior
vena cava collapsibility by bedside ultrasonography.1,5,13
Equally important, many of these newer technologies do
not require invasive, intravascular catheter placement and
permit continuous, beat-to-beat variability assessment. In a
recent meta-analysis, Aya and associates2 examined the
effectiveness of perioperative monitoring and manipulation
of hemodynamic parameters in the management of cardiac
surgical patients. Of the 5 trials meeting the criteria to be
included in their analysis, only 1 reported the use of a pulmo-
nary artery catheter, with the remainder using dynamic car-
diac output monitoring devices in the intervention arms of
their respective studies. Aya and colleagues2 reported that
the use of these devices to guide their therapy reduced
morbidity and hospital stay (though not mortality).
The current study by Kang and colleagues is intended to
provide new information on a noninvasive cardiac output
(NICOM) device that measures bioelectric impedance in
patients undergoing isolated aortic valve procedures. Spe-
cifically, Kang and colleagues sought to understand the rela-
tionship of the bioreactance NICOM device across a range
of mechanical ventilation tidal volumes and positive end-
expiratory pressure levels. They used a passive leg raise
to assess patient baseline fluid responsiveness. The passive
leg raising test, which delivers a reversible endogenous fluid
challenge by increasing venous return, serves to highlight
that simple bedside maneuvers can aid in the determination
of the heart sensitivity to alterations in preload.5
The main clinical impact of the findings of Kang and col-
leagues is that higher levels of positive end-expiratory pres-
sure (a positive end-expiratory pressure of 10 cm H2O)
altered the optimal cutoff value for fluid responsiveness, as
measured by the studied device. Kang and colleagues there-
fore advocate that careful interpretation of stroke volume
variation for fluidmanagement is required to prevent volume
overload under different mechanical ventilation conditions.
Their observations are limited, however, to relatively young
patients undergoing isolated aortic valve replacements. It is
unclear whether this relationship would persist in patients in
with abnormal left atrial pressure (such as those with severe
mitral valve disease or poor left ventricular function).gery c December 2014
Arora Editorial CommentaryFurthermore, it is unclear what impact chest wall edema or
pleural effusions would have on the accuracy of the bio-
impendence measured by the studied NICOM device.
Finally, Kang and colleagues allocated patients to the vol-
ume ‘‘responsive’’ group after an observed 7% increase in
measured cardiac output by the studied NICOM device in
response to a straight leg raise, but they did not use other
monitoring devices (thermodilution, pulse pressure varia-
tion, or other) to validate the NICOM definition of volume
responsiveness in this patient population.
Nonetheless the results presented in the article of Kang
and colleagues serve as a reminder that despite the potential
value of NICOMdevices to assist with goal-directed therapy,
the use of the information provided by these tools needs to be
carefully considered within the clinical context of each
patient and variable conditions that are constantly changing
(such as mechanical ventilator settings). Further validation
studies across a wide variety of cardiopulmonary pathologies
are required to determine the utility of NICOMdevices in the
care of the complex postoperative cardiac surgical patient.
I acknowledge the assistance and content provided by
Drs Rohit Singal (Winnipeg, Alberta, Canada), Sean M.
Bagshaw (Edmonton, Alberta, Canada), and Eric Seely
(San Francisco, Calif) in the generation of this commentary.
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